Linda Chang
2017 - Osiris Therapeutics
In 2017, Linda Chang earned a total compensation of $277.4K as Former Chief Financial Officer at Osiris Therapeutics.
Compensation breakdown
Bonus | $70,000 |
---|---|
Salary | $203,703 |
Other | $3,704 |
Total | $277,407 |
Chang received $203.7K in salary, accounting for 73% of the total pay in 2017.
Chang also received $70K in bonus and $3.7K in other compensation.
Rankings
In 2017, Linda Chang's compensation ranked 13,514th out of 14,666 executives tracked by ExecPay. In other words, Chang earned more than 7.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 13,514 out of 14,666 | 8th |
Division Manufacturing | 5,312 out of 5,772 | 8th |
Major group Chemicals And Allied Products | 1,916 out of 2,075 | 8th |
Industry group Drugs | 1,599 out of 1,731 | 8th |
Industry Biological Products, Except Diagnostic Substances | 294 out of 313 | 6th |
Source: SEC filing on May 11, 2018.
Chang's colleagues
We found six more compensation records of executives who worked with Linda Chang at Osiris Therapeutics in 2017.
2017
Alla Danilkovitch
Osiris Therapeutics
Chief Scientific Officer
2017
Jason Keefer
Osiris Therapeutics
Chief Executive Officer
2017
Linda Palczuk
Osiris Therapeutics
Chief Executive Officer
2017
David Dresner
Osiris Therapeutics
Chief Executive Officer
2017
Gregory Law
Osiris Therapeutics
Chief Financial Officer
2017
R Avendano
Osiris Therapeutics